HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508-263-2900
http://www.hologic.com

Sector : Healthcare
Industry : Medical Instruments & Supplies
Full Time Employees : 6,252

Key Executives

Name Title Pay Exercised Year Born
Mr. Stephen P. MacMillan Chairman, CEO & Pres 2.78M N/A 1964
Ms. Karleen M. Oberton Chief Financial Officer 2.67M 257.27k 1970
Mr. John M. Griffin Gen. Counsel 1.03M N/A 1961
Mr. Peter J. Valenti III Division Pres of Breast & Skeletal Health Solutions 1.04M N/A 1963
Mr. Thomas A. West Division Pres of Diagnostics Solutions 990.14k N/A 1964
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. The company offers Aptima molecular diagnostic assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and analytics products, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, and breast biopsy and biopsy site markers, as well as localization, specimen radiology, ultrasound, and connectivity solutions. In addition, the company offers Selenia Dimensions and 3Dimensions gantries for performing 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D software products; SecurView Workstations; computer aided detection systems; and stereotactic breast biopsy systems. Further, it provides SculpSure, PicoSure, and MonaLisa Touch aesthetic treatment systems; TempSure, a radio frequency energy sourced platform; and MedLite and other products, and system components for medical aesthetics. Additionally, the company offers NovaSure, an endometrial ablation system to treat women suffering from abnormal uterine bleeding; MyoSure surgical products for removal of fibroids, and uterine polyps and other pathology; and Horizon DXA System and Fluoroscan Insight FD skeletal health products. It sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Corporate Governance

Hologic, Inc.’s ISS Governance QualityScore as of April 1, 2019 is 10. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) . Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.